Clinical Trial Detail

NCT ID NCT02050009
Title Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

ovarian cancer

fallopian tube cancer

peritoneal carcinoma

Therapies

Carboplatin + Metformin + Paclitaxel

Age Groups: adult

No variant requirements are available.